← Leaderboards
Hua Lin
Forkhead Biotherapeutics, Inc.
$255,412
Attributed
$255,412
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$255,412 · 1
By mechanism
R43$255,412 · 1
Top collaborators
No co-investigators on record.
Most similar at Forkhead Biotherapeutics, Inc.
Same institution · by research overlap
- Sandro Belvedere$584,112
Others in their field
Other Emerging Leaders on “Analog”
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,023,002
- Jeffrey Reich · Sparian Biosciences, Inc.$14,845,721
- Thomas Dick · Rbhs-New Jersey Medical School$14,469,725
- Terry Roemer · Prokaryotics, Inc.$14,198,753
Research focus
AnalogArtificial PancreasAutoimmune ProcessAutoimmunityAwardBaseBiological Response Modifier TherapyBloodBlood GlucoseBlood Glucose RegulationBlood VesselsCell PhysiologyCellsCell SecretionChronicClinical DevelopmentCollaborationsComplementDiabetes MellitusDiabetic MouseDisease ModelDominant-Negative MutationDoseAblation